EdgeMarket › What Kohlberg Kravis Roberts & Co. L.P. reported owning
What Kohlberg Kravis Roberts & Co. L.P. reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
5.3BPositions
92Quarter
2026-03-31Shown below
50largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. | 1.8B | 33.3% | 41.8M | 58.87 | +149.1% |
| HSIC HENRY SCHEIN INC | 1.2B | 21.6% | 15.7M | 88.50 | +28.9% |
| BBIO BridgeBio Pharma, Inc. | 984.8M | 18.4% | 13.3M | 81.50 | +66.7% |
| CRGY Crescent Energy Co | 386.8M | 7.2% | 28.7M | 14.06 | +51.5% |
| NIQ NIQ Global Intelligence plc | 341.4M | 6.4% | 30.0M | 18.78 | +8.7% |
| BV BrightView Holdings, Inc. | 257.6M | 4.8% | 21.5M | 11.30 | -22.2% |
| KREF KKR Real Estate Finance Trust Inc. | 61.2M | 1.1% | 10.0M | 7.58 | -18.8% |
| PSKY Paramount Skydance Corp | 49.9M | 0.9% | 5.5M | 10.35 | -26.0% |
| unmapped CUSIP 03040WBE4 | 34.5M | 0.6% | 34.5M | — | — |
| unmapped CUSIP 852234AJ2 | 31.7M | 0.6% | 31.8M | — | — |
| OXLC Oxford Lane Capital Corp. | 31.2M | 0.6% | 3.2M | 9.28 | -45.7% |
| BHC Bausch Health Companies Inc. | 28.3M | 0.5% | 5.2M | 6.44 | -15.0% |
| unmapped CUSIP 665531AJ8 | 21.1M | 0.4% | 19.2M | — | — |
| unmapped CUSIP 45258DAB1 | 18.2M | 0.3% | 20.1M | — | — |
| unmapped CUSIP 78573NAK8 | 13.2M | 0.2% | 13.2M | — | — |
| unmapped CUSIP 69352PAS2 | 12.7M | 0.2% | 10.8M | — | — |
| unmapped CUSIP 09257WAE0 | 10.6M | 0.2% | 10.6M | — | — |
| FSK FS KKR Capital Corp | 10.0M | 0.2% | 980.6K | 11.91 | -32.9% |
| unmapped CUSIP 92939UAR7 | 9.9M | 0.2% | 8.0M | — | — |
| unmapped CUSIP 75737FAE8 | 7.2M | 0.1% | 7.6M | — | — |
| unmapped CUSIP 501812AD3 | 7.0M | 0.1% | 5.8M | — | — |
| unmapped CUSIP 47215PAJ5 | 7.0M | 0.1% | 7.0M | — | — |
| TEM Tempus AI, Inc. | 5.3M | 0.1% | 117.7K | 72.69 | -0.8% |
| NCLH Norwegian Cruise Line Holdings Ltd. | 5.1M | 0.1% | 273.7K | 17.24 | -27.7% |
| CHRS Coherus Oncology, Inc. | 5.1M | 0.1% | 3.0M | 1.42 | +32.7% |
| unmapped CUSIP 87918AAF2 | 4.5M | 0.1% | 4.7M | — | — |
| unmapped CUSIP 83304AAH9 | 3.6M | 0.1% | 3.9M | — | — |
| unmapped CUSIP 59001ABF8 | 2.6M | 0.0% | 2.6M | — | — |
| unmapped CUSIP 974637AF7 | 2.5M | 0.0% | 2.8M | — | — |
| unmapped CUSIP 682189AU9 | 2.2M | 0.0% | 2.3M | — | — |
| unmapped CUSIP 922280AD4 | 2.1M | 0.0% | 2.4M | — | — |
| unmapped CUSIP 472145AH4 | 2.1M | 0.0% | 1.5M | — | — |
| unmapped CUSIP 70202LAD4 | 2.0M | 0.0% | 2.0M | — | — |
| unmapped CUSIP 81180WBL4 | 1.9M | 0.0% | 395.0K | — | — |
| unmapped CUSIP 67059NAK4 | 1.7M | 0.0% | 1.9M | — | — |
| unmapped CUSIP 538034BA6 | 1.6M | 0.0% | 1.1M | — | — |
| unmapped CUSIP 902681AB1 | 1.5M | 0.0% | 1.1M | — | — |
| unmapped CUSIP 465741AQ9 | 1.5M | 0.0% | 1.5M | — | — |
| unmapped CUSIP 55306NAB0 | 1.4M | 0.0% | 859.0K | — | — |
| unmapped CUSIP 68213NAF6 | 1.4M | 0.0% | 1.4M | — | — |
| unmapped CUSIP 55024UAF6 | 1.3M | 0.0% | 245.0K | — | — |
| unmapped CUSIP 163072AC5 | 1.3M | 0.0% | 1.3M | — | — |
| unmapped CUSIP 958102AT2 | 1.3M | 0.0% | 180.0K | — | — |
| unmapped CUSIP 40131MAD1 | 1.3M | 0.0% | 745.0K | — | — |
| unmapped CUSIP 833445AD1 | 1.2M | 0.0% | 1.0M | — | — |
| unmapped CUSIP 19240QAA0 | 1.2M | 0.0% | 990.0K | — | — |
| unmapped CUSIP 462222AF7 | 1.1M | 0.0% | 760.0K | — | — |
| unmapped CUSIP 23804LAD5 | 1.1M | 0.0% | 1.2M | — | — |
| unmapped CUSIP 737446AT1 | 1.1M | 0.0% | 1.0M | — | — |
| unmapped CUSIP 194014AB2 | 1.1M | 0.0% | 1.2M | — | — |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →